Re-emergence of cholera vaccine

Journal of Travel Medicine

Volumn 4, Issue 2, 1997, Pages 58-60

  Berger, Stephen A ^a   Shapiro, Itzhak ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; INACTIVATED VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; CHOLERA; DIARRHEA; EDITORIAL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; VIBRIO CHOLERAE;

EID: 0030751869     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8305.1997.tb00780.x     Document Type: Editorial

References (22)

1. McNeil WH. Plagues and peoples. New York: Doubleday, 1976:230-234.
2. Kaper JB, Morris JG Jr, Levine MM. Cholera. Clin Microbiol Rev 1995;8:48-86.
3. World Health Organization. Cholera in 1995. Wkly Epidemiol Rec 1996;71:157-163.
4. Dan M. Bacterial infections. In: Berger SA, ed. The infectious diseases of Israel. Jerusalem: Gefen, 1991:20-21.
5. Rogol M, Sechter I. Cholera in Israel, 1970-1987 [Abstract]. Isr J Med Sci 1988;24:384.
6. Lutzker E, Jochnowitz C, Haffkine W. Pioneer of cholera vaccine. Amer Soc Microbiol News 1987;7:366-369.
7. Chandrasekar C. Statistical assessment of the assessment of the efficacy of anti-cholera inoculation from the data of 63 cheris in South Sercot district. Indian J Med Res 1947;35:153.
8. Sack DA, Cadoz M. Cholera vaccines. In: Plotkin SA, Mortimer EA Jr, eds. Vaccines. 2nd Ed. Philadelphia: W.B. Saunders, 1994:635-636.
9. Benenson AS, Mosley WH, Fahimuddin M, Oseasohn RO. Cholera vaccine field trials in East Pakistan. 2. Effectiveness in the field. Bull World Health Organ 1968;38:359-372.
10. Mosley WH, Aziz KMA, Rahman ASMM, et al. Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 4. Five years of observation with a practical assessment of the role of a cholera vaccine in cholera control programmes. Bull World Health Organ 1972;47:229-238.
11. Pal SC, Deb BC, Gupta PGS, et al. A controlled field trial of an aluminum phosphate adsorbed cholera vaccine in Calcutta. Bull World Health Organ 1980;58:741-745.
12. Azurin JC, Cruz A, Pesigan TP, et al. A controlled field trial of the effectiveness of cholera and cholera el tor vaccines in the Philippines. Bull World Health Organ 1967;37:703-727.
13. Cryz SJ Jr, Que JU, Levine MM, et al. Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults. Infect Immun 1995;63:1336-1339.
14. World Health Organization. Cholera in 1994, part II. Wkly Epidemiol Rec 1995;70:209-210.
15. Berger SA, Young NA, Edberg SC. Relationship between infectious diseases and human blood type. Eur J Clin Microbiol Infect Dis 1989;8:681-689.
16. Clemens J, Rao M, Sack D, et al. Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines. Am J Epidemiol 1995; 142:759-764.
17. Begue RE, Castellares G, Cabezas C, et al. Immunogenicity in Peruvian volunteers of a booster dose of oral cholera vaccine consisting of whole cells plus recombinant B subunit. Infect Immun 1995;63:3726-3728.
18. Petoh H, Siitonen A, Kyronseppa H, et al. Prevention of travellers' diarrhoea by oral B-subunit/whole cell cholera vaccine. Lancet 1991;338:1285-1289.
19. Coster TS, Killeen KP, Waldor MK, et al. Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae 0139 vaccine prototype. Lancet 1995;345:949-952.
20. Tacket C, Losonsky G, Nataro JP, et al. Initial clinical studies of CVD 112 Vibrio cholerae 0139 live oral vaccine: safety and efficacy against experimental challenge. J Infect Dis 1995; 172:883-886.
21. Sommer A, Mosley WH. Ineffectiveness of cholera vaccination as an epidemic control measure. Lancet 1973;1:1232-1235.
22. Sommer A, Khan M, Mosley WH. Efficacy of vaccination of family contacts of cholera cases. Lancet 1973;1:1230-1232.